Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.06322 | 76 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.67745 | 80 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.1503 | 76 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.05195 | 75 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.0409 | 75 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.05154 | 77 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.72738 | 74 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.06099 | 76 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.08717 | 76 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.59107 | 79 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.98386 | 75 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.06344 | 75 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.42883 | 79 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.75122 | 74 |